Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis

• Main Authors: Ying Ma (Author), Dongliang Li (Author), Wenfeng Liu (Author), Xiaoxiao Liu (Author), Yingqi Xu (Author), Xinrui Zhong (Author), Fengnan Zhi (Author), Xueling Jia (Author), Yanan Jiang (Author), Yuhua Fan (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background/Aims: Atherosclerosis (AS) is one of the major leading causes of death globally, which is highly correlated with metabolic abnormalities. Resveratrol (REV) exerts beneficial effects on atherosclerosis. Our aim is to clarify the involvement of liver metabolic reprogramming and the atheropr...